Arab Pharma Manufacturers’ Expo 2020

Dur­ing the pan­dem­ic sit­u­a­tion, health­care man­u­fac­tur­ing has remained a top pri­or­i­ty all around the world in terms of con­tin­u­ous invest­ments and expan­sions at the phar­ma man­u­fac­tur­ing facil­i­ties across the world.
The frist online edi­tion of the 3rd ARAB PHARMA MANUFACTURERS’ EXPO 2020 — an inter­na­tion­al exhi­bi­tion on com­plete phar­ma man­u­fac­tur­ing focus­ing Ara­bic coun­tries in Mid­dle East & North Africa (MENA) region has drawn atten­tion of buy­ers and trade pro­fes­sion­als attend­ed from more than 20 coun­tries to vir­tu­al­ly meet the exhibit­ing com­pa­nies for busi­ness net­work­ing and to attend the Tech­nol­o­gy Presentations.
Keep­ing in mind the health advi­sories by the Gov­ern­ment due to the pan­dem­ic, the online Exhi­bi­tion inte­grat­ed all the basic essen­tial fea­tures to the exhibit­ing com­pa­nies to gen­er­ate opti­mum out­put in terms of dis­play and com­mu­ni­ca­tion while par­tic­i­pa­tion in a high­ly cost effec­tive manner.
More than 45 live Tech­nol­o­gy Pre­sen­ta­tions address­ing the lat­est trends and cur­rent prac­tices of phar­ma man­u­fac­tur­ing tech­nolo­gies by the exhibit­ing com­pa­nies span­ning over 6 days as con­cur­rent event along­side the online exhi­bi­tion had remained high­ly resource­ful for phar­ma man­u­fac­tur­ing fra­ter­ni­ty to acquire the tech­nol­o­gy based information.
Over­all, the exhibitors have well appre­ci­at­ed the nov­el con­cept of the online exhi­bi­tion, as it applies all the lat­est tech­ni­cal aspects to offer the opti­mum busi­ness net­work­ing domain bypass­ing all the limitations.
Out­stand­ing ben­e­fits of the exhi­bi­tion are the accel­er­a­tion of an instant busi­ness con­nec­tiv­i­ty, glob­al expo­sure with­out any geo­graph­i­cal bar­ri­ers, ease of acces­si­bil­i­ties and busi­ness net­work­ing through mobile, lap­top or com­put­er, longer exhib­it hours, live chat to engage with prospec­tive sup­pli­ers, live tech­nol­o­gy pre­sen­ta­tions, real-time expe­ri­ence with neg­li­gi­ble invest­ment, options of afford­able pack­ages for cost effec­tive par­tic­i­pa­tion, and, most impor­tant­ly, bypass of sev­er­al oth­er asso­ci­at­ed costs and time.